COMMISSION IMPLEMENTING REGULATION (EU) 2019/139
of 29 January 2019
approving the active substance
Beauveria bassiana
strain IMI389521, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Approval of active substance
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
Article 3
Entry into force
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||
Beauveria bassiana strain IMI389521 Accession number in the CABI Genetic Resource Collection: IMI389521 |
Not applicable |
Max. level of beauvericin: 0,09 mg/kg |
19 February 2019 |
19 February 2029 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain IMI389521, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to:
The compliance with strict maintenance of environmental conditions and quality control analysis during the manufacturing process, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012(2) Conditions of use shall include risk mitigation measures where appropriate. |
ANNEX II
‘130 |
Beauveria bassiana strain IMI389521 Accession number in the CABI Genetic Resource Collection: IMI389521 |
Not applicable |
Max. level of beauvericin: 0,09 mg/kg |
19 February 2019 |
19 February 2029 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain IMI389521, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to:
The compliance with strict maintenance of environmental conditions and quality control analysis during the manufacturing process, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012 (*1). Conditions of use shall include risk mitigation measures where appropriate. |